Cargando…
LncTUG1 contributes to the progression of hepatocellular carcinoma via the miR-144-3p/RRAGD axis and mTOR/S6K pathway
Hepatocellular carcinoma (HCC) is a symptomatic disease involed multi-stage program. Here, we elucidated the molecular mechanism of LncTUG1 in the regulation of HCC evolvement. And that may in all likelyhood supply a innovative latent target for HCC’s diagnoses and prognosis. LncRNA TUG1, miR-144-3p...
Autores principales: | Chen, Weixi, Bai, Zekun, Bai, Wen, Wang, Wei, Guo, Jiapei, Guo, Mengnan, Sai, Yingying, Shi, Jun, Wu, Jinghua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170139/ https://www.ncbi.nlm.nih.gov/pubmed/37160972 http://dx.doi.org/10.1038/s41598-023-33976-5 |
Ejemplares similares
-
The regulatory role and mechanism of lncTUG1 on cartilage apoptosis and inflammation in osteoarthritis
por: Liu, Nan-nan, et al.
Publicado: (2023) -
Epigenetic Regulation of Hepatocellular Carcinoma Progression through the mTOR Signaling Pathway
por: Guo, Mengnan, et al.
Publicado: (2021) -
lncTUG1/miR-144-3p affect the radiosensitivity of esophageal squamous cell carcinoma by competitively regulating c-MET
por: Wang, Pan, et al.
Publicado: (2020) -
LncTUG1 promotes hepatocellular carcinoma immune evasion via upregulating PD-L1 expression
por: Wu, Rongshou, et al.
Publicado: (2023) -
LncTUG1 ameliorates renal tubular fibrosis in experimental diabetic nephropathy through the miR-145-5p/dual-specificity phosphatase 6 axis
por: Wang, Taoxia, et al.
Publicado: (2023)